NEO NeoGenomics, Inc. - Common Stock
$16,21
Prezzo · Ago 18, 2026
Fondamentali al Lug 28, 2026
Intervallo 52 sett.
$6–$17
94% of range
Rating Analisti
BUY
16 analysts
Prezzo Obiettivo
$20
+22% upside
P/E (TTM)
-68.3
ROE
-12.8%
Margine di Profitto Netto
-14.8%
Informazioni su NeoGenomics, Inc. - Common Stock Panoramica della società da Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Leggi di più
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
NEO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$16.21
Capitalizzazione di Mercato
$2.10B
P/E (TTM)
-68.3
EPS (TTM)
—
Ricavi (TTM)
$727M
Rendimento div.
—
ROE
-12.8%
D/E Debito/Patrimonio
0.4
Intervallo 52 sett.
$6 – $17
NEO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$727M
2016-12-31
→
2025-12-31
EPS
—
Flusso di cassa libero
$-22M
2017-12-31
→
2025-12-31
Margini
-14.8%
2019-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
NEO
Mediana dei peer
P/E (TTM)
-68.3
32.1
P/S (TTM)
2.9
0.8
P/B
2.5
2.0
EV / EBITDA
-19.7
—
Price / FCF (Prezzo / FCF)
-96.5
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
NEO
Mediana dei peer
Gross Margin (Margine lordo)
43.2%
27.6%
Operating Margin (Margine Operativo)
-15.9%
—
Net Profit Margin (Margine di Profitto Netto)
-14.8%
0.79%
ROA
-7.2%
1.3%
ROE
-12.8%
3.9%
ROIC
-9.6%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
NEO
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
0.4
—
Current Ratio (Rapporto corrente)
4.3
1.3
Quick Ratio
3.6
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
NEO
Mediana dei peer
Revenue YoY (Ricavi YoY)
10.1%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
12.6%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
10.3%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
NEO
Mediana dei peer
NEO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
16 analisti
- Acquisto forte 4 25,0%
- Compra 7 43,8%
- Mantieni 5 31,2%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
9 analisti · 2026-08-14
Mediana
$19.00
Ora
$16.21
Basso
$16.00
Alto
$35.00
Target mediano
$19.00
+17,2%
Target medio
$19.72
+21,7%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.01%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.05 | $0.03 | 0.02% |
| 31 Marzo 2026 | $0.01 | $0.01 | 0.00% |
| 31 Dicembre 2025 | $0.06 | $0.04 | 0.02% |
| 30 Settembre 2025 | $0.03 | $0.02 | 0.01% |
| 30 Giugno 2025 | $0.03 | $0.02 | 0.01% |
| 31 Marzo 2025 | $0.00 | $-0.01 | 0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Stato Patrimoniale 29
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Flusso di cassa 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Stato Patrimoniale 27
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Flusso di cassa 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Valutazione (TTM) 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $727M | $661M | $592M | $510M | $484M |
| Margine Lordo % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Margine Operativo % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Utile netto | $-108M | $-79M | $-88M | $-144M | $-8M |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.4 | 0.6 | — | — | — |
| Rapporto corrente | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-22M | $-34M | $-31M | $-97M | $-91M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 299 filer · $1.8B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 64 (+22 vs trimestre precedente) | 38 (+1 vs trimestre precedente) | 93 (+20 vs trimestre precedente) | 59 (-26 vs trimestre precedente) | +33.5M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179.158.241 | 12.279.523 | 9,76% | Azioni |
| VANGUARD GROUP INC | $150.953.759 | 12.836.204 | 8,22% | Azioni |
| FIRST TRUST ADVISORS LP | $147.552.477 | 10.113.261 | 8,04% | Azioni |
| Greenhouse Funds LLLP | $125.097.724 | 8.574.210 | 6,82% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.615.272 | 8.061.362 | 6,41% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.082.418 | 5.763.017 | 4,58% | Azioni |
| STATE STREET CORP | $78.257.609 | 5.363.784 | 4,26% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73.501.000 | 5.037.787 | 4,00% | Azioni |
| BRAIDWELL LP | $71.756.567 | 4.918.202 | 3,91% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61.886.083 | 4.342.883 | 3,37% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50.558.727 | 3.465.300 | 2,75% | Opzione Call |
| MILLENNIUM MANAGEMENT LLC | $44.930.518 | 3.079.542 | 2,45% | Azioni |
| TORONTO DOMINION BANK | $43.770.000 | 3.000.000 | 2,38% | Opzione Call |
| GEODE CAPITAL MANAGEMENT, LLC | $42.933.596 | 2.942.009 | 2,34% | Azioni |
| Driehaus Capital Management LLC | $36.604.049 | 2.508.845 | 1,99% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34.896.129 | 2.391.784 | 1,90% | Azioni |
| AMERICAN CAPITAL MANAGEMENT INC | $32.648.145 | 2.237.707 | 1,78% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $32.593.724 | 2.233.977 | 1,78% | Azioni |
| UBS Group AG | $32.581.659 | 2.233.150 | 1,78% | Opzione Call |
| LOOMIS SAYLES & CO L P | $30.838.504 | 2.113.674 | 1,68% | Azioni |
| Aberdeen Group plc | $28.180.950 | 1.931.525 | 1,54% | Azioni |
| D. E. Shaw & Co., Inc. | $27.938.858 | 1.914.932 | 1,52% | Azioni |
| GLENMEDE TRUST CO NA | $20.985.657 | 1.438.359 | 1,14% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.689.018 | 1.212.407 | 0,96% | Azioni |
| SEGALL BRYANT & HAMILL, LLC | $15.850.518 | 1.086.396 | 0,86% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $12.685.640 | 869.475 | 0,69% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $11.918.848 | 816.919 | 0,65% | Azioni |
| SAMLYN CAPITAL, LLC | $11.869.359 | 813.527 | 0,65% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $11.707.337 | 802.422 | 0,64% | Azioni |
| Glenmede Investment Management, LP | $11.359.995 | 1.471.502 | 0,62% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $9.141.555 | 626.563 | 0,50% | Azioni |
| HighMark Wealth Management LLC | $8.936.871 | 612.534 | 0,49% | Azioni |
| JUPITER ASSET MANAGEMENT LTD | $7.841.935 | 537.487 | 0,43% | Azioni |
| Public Sector Pension Investment Board | $6.526.545 | 447.330 | 0,36% | Azioni |
| Trexquant Investment LP | $6.358.074 | 435.783 | 0,35% | Azioni |
| GOLDMAN SACHS GROUP INC | $5.559.884 | 381.075 | 0,30% | Azioni |
| Bank of New York Mellon Corp | $5.554.938 | 380.736 | 0,30% | Azioni |
| Granite Investment Partners, LLC | $5.181.507 | 355.141 | 0,28% | Azioni |
| RHUMBLINE ADVISERS | $4.624.054 | 316.935 | 0,25% | Azioni |
| AMERIPRISE FINANCIAL INC | $4.623.822 | 316.917 | 0,25% | Azioni |
| Weiss Asset Management LP | $4.171.558 | 285.919 | 0,23% | Azioni |
| Swiss National Bank | $3.800.695 | 260.500 | 0,21% | Azioni |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3.770.056 | 258.400 | 0,21% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.680.109 | 252.235 | 0,20% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.455.481 | 236.839 | 0,19% | Azioni |
| FMR LLC | $3.409.026 | 233.655 | 0,19% | Azioni |
| Squarepoint Ops LLC | $3.239.505 | 222.036 | 0,18% | Azioni |
| ExodusPoint Capital Management, LP | $3.128.811 | 214.449 | 0,17% | Azioni |
| Legal & General Group Plc | $2.907.700 | 199.294 | 0,16% | Azioni |
| PEAK6 LLC | $2.651.003 | 181.700 | 0,14% | Opzione Call |
| FEDERATED HERMES, INC. | $2.510.064 | 172.040 | 0,14% | Azioni |
| BANK OF AMERICA CORP /DE/ | $2.221.357 | 152.252 | 0,12% | Azioni |
| WHITE PINE CAPITAL LLC | $2.167.184 | 148.539 | 0,12% | Azioni |
| PRUDENTIAL FINANCIAL INC | $2.017.870 | 138.305 | 0,11% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $1.987.158 | 136.200 | 0,11% | Azioni |
| BlackRock, Inc. | $1.962.691 | 134.523 | 0,11% | Azioni |
| WELLS FARGO & COMPANY/MN | $1.943.067 | 133.178 | 0,11% | Azioni |
| STEELHEAD PARTNERS LLC | $1.885.028 | 129.200 | 0,10% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $1.787.859 | 122.540 | 0,10% | Azioni |
| Greenhouse Funds LLLP | $1.689.522 | 115.800 | 0,09% | Opzione Call |
| PERKINS CAPITAL MANAGEMENT INC | $1.605.483 | 110.040 | 0,09% | Azioni |
| GABELLI FUNDS LLC | $1.597.605 | 109.500 | 0,09% | Azioni |
| ARISTEIA CAPITAL, L.L.C. | $1.571.343 | 107.700 | 0,09% | Azioni |
| IEQ CAPITAL, LLC | $1.524.305 | 104.476 | 0,08% | Azioni |
| Verition Fund Management LLC | $1.477.019 | 101.235 | 0,08% | Azioni |
| GAMCO INVESTORS, INC. ET AL | $1.459.000 | 100.000 | 0,08% | Azioni |
| Fernwood Investment Management, LLC | $1.453.536 | 88.200 | 0,08% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.440.244 | 194.103 | 0,08% | Azioni |
| XTX Topco Ltd | $1.413.552 | 96.885 | 0,08% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.403.354 | 96.186 | 0,08% | Azioni |
| CITADEL ADVISORS LLC | $1.324.772 | 90.800 | 0,07% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.279.178 | 87.675 | 0,07% | Azioni |
| Curi Capital, LLC | $1.256.666 | 86.132 | 0,07% | Azioni |
| MFG WEALTH MANAGEMENT, INC. | $1.217.711 | 83.462 | 0,07% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $1.189.723 | 160.340 | 0,06% | Azioni |
| MetLife Investment Management, LLC | $1.120.293 | 76.785 | 0,06% | Azioni |
| Mariner, LLC | $1.117.405 | 76.587 | 0,06% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.039.421 | 71.242 | 0,06% | Azioni |
| TWO SIGMA ADVISERS, LP | $983.136 | 83.600 | 0,05% | Azioni |
| Russell Investments Group, Ltd. | $967.068 | 66.283 | 0,05% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $962.429 | 65.965 | 0,05% | Azioni |
| MORGAN STANLEY | $954.638 | 65.431 | 0,05% | Azioni |
| Quantinno Capital Management LP | $945.359 | 64.795 | 0,05% | Azioni |
| Illinois Municipal Retirement Fund | $932.520 | 63.915 | 0,05% | Azioni |
| WINTON GROUP Ltd | $924.700 | 63.379 | 0,05% | Azioni |
| Quantbot Technologies LP | $922.540 | 63.231 | 0,05% | Azioni |
| CHOREO, LLC | $889.115 | 60.940 | 0,05% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884.373 | 60.615 | 0,05% | Azioni |
| MOODY NATIONAL BANK TRUST DIVISION | $860.445 | 58.975 | 0,05% | Azioni |
| Louisiana State Employees Retirement System | $833.089 | 57.100 | 0,05% | Azioni |
| SIMPLEX TRADING, LLC | $796.453 | 54.589 | 0,04% | Azioni |
| JANE STREET GROUP, LLC | $786.401 | 53.900 | 0,04% | Opzione Call |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786.109 | 53.880 | 0,04% | Azioni |
| Teton Advisors, LLC | $774.729 | 53.100 | 0,04% | Azioni |
| Invesco Ltd. | $766.515 | 52.537 | 0,04% | Azioni |
| COMMERCE BANK | $764.632 | 52.408 | 0,04% | Azioni |
| Vanguard Global Advisers, LLC | $741.070 | 50.793 | 0,04% | Azioni |
| BARD ASSOCIATES INC | $683.761 | 46.865 | 0,04% | Azioni |
| Alamea Verwaltungs GmbH | $683.702 | 46.861 | 0,04% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $674.467 | 46.228 | 0,04% | Azioni |
Insider aziendali 52 insider · 30 dirigenti · 23 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 01 Giugno 2025 M | 20.166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 23 Febbraio 2025 M | 641.585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 01 Marzo 2022 A | 368.051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 11 Maggio 2025 M | 168.332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 28 Aprile 2022 M | 191.548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 01 Marzo 2019 A | 10.944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 23 Febbraio 2024 A | 148.455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 01 Agosto 2022 A | 43.216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 02 Marzo 2022 F | 244.157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 01 Marzo 2022 A | 33.443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 30 Dicembre 2021 A | 41.280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 25 Maggio 2021 M | 150.101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 11 Maggio 2025 M | 108.280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 01 Settembre 2025 F | 47.940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 23 Febbraio 2025 M | 109.755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 01 Aprile 2023 F | 82.673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 02 Marzo 2023 F | 29.765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 01 Aprile 2022 A | 158.684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 01 Marzo 2022 A | 147.396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 11 Gennaio 2022 M | 49.361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 30 Dicembre 2021 A | 48.615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 22 Aprile 2021 M | 130.847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 02 Marzo 2021 A | 60.643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 22 Ottobre 2018 M | 45.953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 10 Maggio 2018 X | 4.500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 25 Maggio 2017 A | 60.692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 28 Gennaio 2016 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 29 Dicembre 2015 X | 51.218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 22 Maggio 2014 X | 8.439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 18 Maggio 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Direttore | 23 Giugno 2026 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Direttore | 15 Giugno 2026 S | 86.115 | 0 | 2 | $-118.824 |
| Marjorie C Green | Direttore | 01 Giugno 2026 A | 22.964 | 0 | 0 | $0 |
| Neil Gunn | Direttore | 01 Giugno 2026 A | 51.177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Direttore | 01 Giugno 2026 A | 67.086 | 0 | 0 | $0 |
| David Brian Perez | Direttore | 01 Giugno 2026 A | 56.967 | 0 | 0 | $0 |
| John P. Kenny | Direttore | 01 Giugno 2026 A | 5.893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Direttore | 01 Giugno 2026 A | 75.421 | 0 | 0 | $0 |
| Felicia Williams | Direttore | 01 Giugno 2026 A | 30.237 | 0 | 0 | $0 |
| Elizabeth Floegel | Direttore | 01 Giugno 2025 A | 23.590 | 0 | 0 | $0 |
| Alison L. Hannah | Direttore | 01 Giugno 2025 M | 131.023 | 0 | 0 | $0 |
| Bruce K Crowther | Direttore | 10 Agosto 2023 A | 65.120 | 0 | 0 | $0 |
| Rachel A Stahler | Direttore | 10 Giugno 2022 A | 21.335 | 0 | 0 | $0 |
| David Daly | Direttore | 10 Giugno 2022 A | 17.179 | 0 | 0 | $0 |
| Kevin C Johnson | Direttore | 22 Dicembre 2021 M | 37.398 | 0 | 0 | $0 |
| Douglas M Van Oort | Direttore | 01 Agosto 2021 F | 2.468.797 | 0 | 0 | $0 |
| Steven C Jones | Direttore | 07 Gennaio 2021 M | 90.218 | 0 | 0 | $0 |
| Raymond R Hipp | Direttore | 16 Novembre 2020 S | 66.800 | 0 | 0 | $0 |
| William J Robison | Direttore | 25 Maggio 2017 A | 183.348 | 0 | 0 | $0 |
| Michael T Dent | Direttore | 04 Dicembre 2014 S | 1.384.150 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 12 Aprile 2007 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 62 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,12% | 167.212 SH | 08 Agosto 2026 | Giornaliero |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,09% | 113.008 SH | 08 Agosto 2026 | Giornaliero |
| LFSC · RBB Fund, Inc. | 0,43% | 43.071 NS | 31 Maggio 2026 | N-PORT |
| IHF · iShares Trust | 0,31% | 243.554 SH | 08 Agosto 2026 | Giornaliero |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 154.408 NS | 30 Aprile 2026 | N-PORT |
| IJT · iShares Trust | 0,13% | 700.692 SH | 08 Agosto 2026 | Giornaliero |
| XJR · iShares Trust | 0,13% | 15.435 SH | 08 Agosto 2026 | Giornaliero |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,12% | 19.262 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 211.878 SH | 08 Agosto 2026 | Giornaliero |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,12% | 89.895 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,12% | 1.117.630 SH | 08 Agosto 2026 | Giornaliero |
| IJR · iShares Trust | 0,11% | 7.947.524 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 104.297 SH | 08 Agosto 2026 | Giornaliero |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 455.144 SH | 08 Agosto 2026 | Giornaliero |
| NUSC · Nushares ETF Trust | 0,10% | 135.666 NS | 30 Aprile 2026 | N-PORT |
| IJS · iShares Trust | 0,09% | 489.210 SH | 08 Agosto 2026 | Giornaliero |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,09% | 116.046 SH | 08 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,09% | 158.897 SH | 08 Agosto 2026 | Giornaliero |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 93.313 NS | 30 Aprile 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 13.856 NS | 31 Maggio 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 85.056 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,06% | 3.340.583 SH | 08 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,06% | 40.428 SH | 08 Agosto 2026 | Giornaliero |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 49.165 NS | 30 Aprile 2026 | N-PORT |
| SAA · ProShares Trust | 0,06% | 1.546 NS | 31 Maggio 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 757.699 SH | 08 Agosto 2026 | Giornaliero |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 33.295 NS | 30 Aprile 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 1.728.845 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 106.278 NS | 31 Maggio 2026 | N-PORT |
| RSSL · Global X Funds | 0,04% | 55.874 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 6.071 NS | 31 Maggio 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 5.811 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,03% | 388.986 SH | 08 Agosto 2026 | Giornaliero |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 628.556 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 425.333 NS | 30 Aprile 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 14.399 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.492.431 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2.990.594 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,02% | 4.748 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 60.531 NS | 30 Aprile 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 7.690 SH | 08 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | 0,02% | 45.201 SH | 08 Agosto 2026 | Giornaliero |
| URTY · ProShares Trust | 0,01% | 4.804 NS | 31 Maggio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 5.288 NS | 30 Aprile 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 113.167 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.627 SH | 08 Agosto 2026 | Giornaliero |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 5.219 NS | 31 Maggio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 339.840 NS | 30 Aprile 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 15.340 NS | 30 Aprile 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 121 NS | 31 Maggio 2026 | N-PORT |